Causes of Death in Follicular Lymphoma: a Single Center Retrospective Analysis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02951871

Enrollment

237

Registered

2016-11-01

Start date

2000-01-31

Completion date

2016-07-31

Last updated

2016-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This Study Describes the Different Causes of Death in 237 FL Patients

Keywords

Follicular lymphoma; death, rituximab, treatment related toxicity

Brief summary

Background.Although the life expectancy of patients with FL has recently increased, notably since the introduction of rituximab in combination with chemotherapy, little is known regarding the precise causes of patients death. Patients and methods'. This study describes the different causes of death in FL patients among followed since 2000 at Lyon University Hospital, centre Léon Bérard and Mayo Clinic. The causes of death will be classified as related to lymphoma progression, treatment-related toxicity (including TRM and secondary myelodysplastic syndrome/acute myeloid leukemia), secondary neoplasias, or other.

Interventions

None listed

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* FL patients * patients recorded as deceased

Exclusion criteria

-Other diagnosis than FL

Design outcomes

Primary

Measure	Time frame
overall survival (OS)	OS length was calculated from the date of diagnosis to the date of death

Countries

France

Outcome results